Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Explanatory Note: The purposes of this Amendment No. 2 to Schedule 13G (this "Amendment No. 2") are (i) to correct the number and percentage of the Common Stock of AirSculpt Technologies, Inc. (the "Issuer") beneficially owned by the reporting persons as of September 30, 2025, reported in Amendment No. 1 to Schedule 13G filed on November 14, 2025 ("Amendment No. 1"), and (ii) to report the Reporting Persons' beneficial ownership as of June 30, 2026. As a result of a clerical error, Amendment No. 1 overstated the reporting persons' beneficial ownership by an additional 176,310 shares, and the correct number and percentage of the Issuer's Common Stock beneficially owned by the reporting persons as of September 30, 2025 are 5,169,820 shares and 8.3%. (1) The share number reported in rows 6, 8, and 9 consists of 4,425,000 shares of Common Stock of the Issuer (the "Issuer Shares") held directly by Thrivent White Rose Fund XI Equity Direct, L.P. ("White Rose"). Thrivent Investment Capital Advisors, LLC ("TICA") is the managing member of the general partner of White Rose, Thrivent White Rose GP XI, LLC. Thrivent Financial for Lutherans is the 100% indirect owner of TICA and the owner of approximately 99% of the limited partnership interests of White Rose. On May 20, 2026, White Rose appointed Vesey Street Capital Partners, L.L.C. ("Vesey") as its proxy agent with voting power with respect to the Issuer Shares to be effective until the earlier of twelve months following the date of such appointment and the date on which White Rose ceases to beneficial own or hold of record any of such shares. TICA is the investment adviser of White Rose, and in that capacity has been granted by White Rose shared authority to vote and dispose of White Rose's holding of the Issuer Shares. (2) The percentage reported in row 11 is calculated based on 70,545,681 shares of the Issuer's Common Stock reported to be outstanding as of May 7, 2026 on the Issuer's Form 10-Q for the quarterly period ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The share number reported in rows 6, 8, and 9 consists of 4,425,000 shares of Common Stock of the Issuer (the "Issuer Shares") held directly by Thrivent White Rose Fund XI Equity Direct, L.P. ("White Rose"). Thrivent Investment Capital Advisors, LLC ("TICA") is the managing member of the general partner of White Rose, Thrivent White Rose GP XI, LLC. Thrivent Financial for Lutherans is the 100% indirect owner of TICA and the owner of approximately 99% of the limited partnership interests of White Rose. On May 20, 2026, White Rose appointed Vesey Street Capital Partners, L.L.C. ("Vesey") as its proxy agent with voting power with respect to the Issuer Shares to be effective until the earlier of twelve months following the date of such appointment and the date on which White Rose ceases to beneficial own or hold of record any of such shares. TICA is the investment adviser of White Rose, and in that capacity has been granted by White Rose shared authority to vote and dispose of White Rose's holding of the Issuer Shares. (2) The percentage reported in row 11 is calculated based on 70,545,681 shares of the Issuer's Common Stock reported to be outstanding as of May 7, 2026 on the Issuer's Form 10-Q for the quarterly period ended March 31, 2026.


SCHEDULE 13G



 
THRIVENT FINANCIAL FOR LUTHERANS
 
Signature:/s/ Jen Wilson
Name/Title:Jen Wilson / Vice President - Head of Private Investments
Date:08/10/2026
 
Thrivent Investment Capital Advisors, LLC
 
Signature:/s/ Jen Wilson
Name/Title:Jen Wilson / President, Senior Managing Director
Date:08/10/2026